Live Breaking News & Updates on புகழ்பெற்ற புதுமைப்பித்தன் விருது

Stay updated with breaking news from புகழ்பெற்ற புதுமைப்பித்தன் விருது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Research roundup: Recent grants and publications for Emory faculty and staff

Emory and NIH continue public-private partnership advancing Alzheimer’s research
The National Institutes of Health is launching the next version of AMP AD (Accelerating Medicines Partnership Alzheimer’s Disease), a public-private partnership that takes an open science, big data approach to identifying biological targets for therapeutic intervention.
The National Institute on Aging will lead research efforts for AMP AD 2.0 and has pledged to contribute $61.4 million over five years. This includes funding six multi-institutional, cross-disciplinary academic research teams, including the team at Goizueta Alzheimer’s Research Center at Emory University, along with a data coordinating center at Sage Bionetworks.
Emory researchers served as a founding academic team for the first iteration of the AMP AD when the initiative began in 2014. Led by Allan Levey and Nicholas T. Seyfried, Emory investigators will play an integral role in AMP AD 2.0 as it seeks to support new t ....

United States , Rollins School , Emory University , Emory University School Of Medicine , Vilma Todri , Scott Lilienfeld , Aliza Wingo , Tom Costello , Ignacio Sanz , Luiz Santos , Laurene Mccullough , Vikas Gupta , Deanna Ferree Womack , Jian Wang , Ahsan Husain , John Hackney , Walter Orenstein , Allen Berger , Tetyana Balyuk , Christopher Scharer , Nawazish Naqvi , Williame Paul , Srikant Rangaraju , Shauna Bowes , Lawrence Boise , Allan Levey ,

Groundbreaking New Study in "Lancet Rheumatology" Shows Potential Strategy for Safer Steroid Use in Lupus

Groundbreaking New Study in Lancet Rheumatology Shows Potential Strategy for Safer Steroid Use in Lupus
Dr. Eric Morand Publishes Results Funded by LRA s Distinguished Innovator Award
News provided by
Share this article
Share this article
NEW YORK, April 1, 2021 /PRNewswire/ Results of critical work funded by the Lupus Research Alliance Distinguished Innovator Award to Dr. Eric Morand suggests a path toward making lupus treatment with steroids effective at lower doses, lessening harmful side effects.
In a study just published in
Lancet Rheumatology, Dr. Morand (with first author rheumatology fellow. Dr. Melissa Northcott) reports identifying a group of biological markers that can indicate how much steroid lupus patients have been exposed to, since the amount that is active in the body is more important than the amount taken. The paper further shows that high activity of proteins made by the immune system, called interferons, can block the eff ....

United States , Eric Morand , Williame Paul , Teodora Staeva , Melissa Northcott , Lupus Research Alliance Board Of Directors , Lupus Research Alliance , Lancet Rheumatology , Results Fulfill Goal , Distinguished Innovator Award , Steroid Resistance , Typei Interferon , Innovator Award , Research Alliance Chief Scientific Officer , Native Americans , Lupus Research , Health Care Amp Hospitals , Medical Pharmaceuticals , Polls And Research , Not For Profit , ஒன்றுபட்டது மாநிலங்களில் , எரிக் மோறண்ட் , மெலிசா நார்த்காட் , லூபஸ் ஆராய்ச்சி கூட்டணி பலகை ஆஃப் இயக்குநர்கள் , லூபஸ் ஆராய்ச்சி கூட்டணி , முடிவுகள் நிறைவேற்றுங்கள் இலக்கு ,